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Handgrip strength, childrena b s t r a c t
Background: Thalassemia is an inherited blood disorder that requires repeated blood transfusions and
chelation regimes. This may lead to restrictions in physical activities, social participation as well as
decreased muscle strength.
Aim: The aim of this study was to evaluate the health-related quality of life (HRQoL), muscular strength
and pain in children with b-thalassemia major.
Patients and method: One hundred and twenty children (60 with b-thalassemia major and 60
age-matched healthy) were participated in a cross-sectional study from both sexes (57 girls and 63 boys)
with ages ranging from two to twelve years. HRQoL (physical, emotional, social and school functioning),
muscular strength and pain were evaluated for all children by using the pediatric quality of life
inventoryTM (PedsQLTM) 4.0 generic core scale, hand-held dynamometer and visual analogue scale (VAS)
respectively.
Results: Children with b-thalassemia major showed a significant decrease in all domains of health-related
quality of life and handgrip strength with a significant increase in VAS score (p  0.0001).
Conclusions: The study concluded that thalassemia as a chronic disease has a negative impact on HRQoL
and muscle strength of children in different age group.
 2018 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Thalassemia is a genetic blood disorder, which is characterized
by decreased synthesis or absence of globin [1]. This synthetic
defect leads to the formation of fragile abnormal red blood cells
(RBC), which can be easily hemolyzed, leading to chronic anemia
[2]. According to clinical and hematological conditions, the severity
of the disease is classified into three categories; beta thalassemia
carrier state, thalassemia intermedia and thalassemia major [3].
The World Health Organization (WHO) recognized thalassemia
as the most prevalent genetic blood disorder in the world, found in
more than 60 countries with a carrier population of up to 150 mil-
lion [4]. This disorder is highly prevalent among children in the
Middle East, Mediterranean region, and South Asia [5].
Thalassemia is a chronic disease and presents with a wide range
of serious clinical and psychological challenges. The effects ofthalassemia on physical health can lead to physical deformity,
growth retardation, and delayed puberty [5–7]. Its impact on phys-
ical appearance, e.g., bone deformities and short stature, also con-
tributes to a poor self-image [5,7]. Severe complications such as
heart failure, cardiac arrhythmia, liver disease, endocrine compli-
cations, and infections are common among thalassemia patients
[8]. These problems do not only affect patients’ physical function-
ing but also their emotional functioning, social functioning and
school functioning, leading to impaired health-related quality of
life (HRQoL) of the patients [5,7,9,10].
Children with thalassemia are less active than their healthy
peers and generally have decreased muscle strength and flexibility
[11]. Pain has become increasingly common and an emergent
complication of thalassemia. The exact mechanism of pain in
thalassemia has not yet been clarified; however, iron overload,
low hemoglobin level, and low bone mass have been suggested
as possible causes [12]. Nevertheless, the current evidence does
not confirm these suggestions. The most frequent sites of pain
were the lower back (82%), the leg (56%), head (48%), and
mid-back (47%). [13].
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illness such as thalassemia are limited. The assessment of HRQoL
in children, especially in children with chronic illness such as tha-
lassemia is particularly important [14].
1.1. Aim of the study
The aim of this study was to evaluate health related quality of




For the purpose of the study, 120 children ranged in age from 2
to 12 years were enrolled in a cross-sectional study from October
2017 to April 2018. 60 children with b-thalassemia major (32 girls
and 28 boys) were selected by a blind physician from the outpa-
tient clinic of ‘‘Abo El-Rish Pediatric Hospital – Cairo University
Hospitals”. In addition, 60 healthy age-matched children with nor-
mal hemoglobin level (25 girls and 35 boys) were selected from
Abo-Bakr El-Sedik Primary school in Sheikh Zayed City. All selected
children were free from musculoskeletal deformities, visual and
auditory impairments. However, children who had associated dis-
ease with b-thalassemia major as leukemia or marked cognitive or
cardiac impairments were excluded from the study. The children
either thalassemic or normal were stratified into three age sub-
groups (I (2–4 years), II (5–7 years) and III (8–12 years). Before
the study, interviews were conducted with the children and their
parents to explain the purpose, procedures as well as potential
benefits of the study and signed a consent form of the ethical com-
mittee, Faculty of Physical therapy, Cairo University prior to partic-
ipation. The study design, protocol and consent forms were carried
out in accordance with the code of ethics of the World Medical
Association (Declaration of Helsinki) for experiments involving
humans.
1.2.2. Instrumentation for evaluation
1.2.2.1. Handgrip strength. The handheld dynamometer has been
shown to be reliable in measuring hand-grip strength in children
[15].Hand-grip strength of the dominent side was measured in
pounds using a hand-held dynamometer (Nicholas Manual Muscle
Test system, Model 01163; Lafayette Instrument Company, Lafay-
ette, IN).
1.2.2.2. Health related quality of life. Assessment of the HRQoL of
children was performed using the pediatric quality of life inven-
toryTM (PedsQLTM) 4.0 generic core scale which was developed to
measure HRQoL in healthy children and adolescent and those with
acute and chronic health problems. PedsQLTM 4.0 is reliable, feasi-
ble, and valid to measure the health outcome of the pediatric pop-
ulation, as it facilitates risk assessment and tracking of community
health [16]. The Arabic version of PedsQLTM 4.0 was considered to
have satisfactory psychometric properties according to a Jordanian
study conducted by Arabiat et al. [17]. A user agreement was
signed with the MAPI Research institute, Lyon, France, prior to
the use of the questionnaire. The PedsQLTM 4.0 generic core scale
was designed to be appropriate for ages of the children. In children
older than 4 years, it includes parallel child self-reports and parent
proxy reports (age ranges 5–7, 8–12 and 13–18 years) and consists
of 23 items. Moreover, in children aged between 2 and 4 years, par-
ent proxy report was used and consists of 21 items. The scale was
applied, and analyzed according to the PedsQLTM administration
guidelines SM. The children were asked to report problems regard-
ing physical functioning (8 items), emotional functioning (5 items),
social functioning (5 items) and school performance (5 items) thathave arisen for the past one month. The items’ responses were
measured on a five-point rating scale which consists of 0 (never
a problem), 1 (almost never a problem), 2 (sometimes a problem),
3 (often a problem), and 4 (almost always a problem), yielding a
total score with corresponding scores of 100, 75, 50, 25, and 0.
The higher score indicating higher QoL, better health or a higher
level of function. The PedsQL has demonstrated good internal con-
sistency and validity in large samples of children with acute and
chronic health conditions, as well as in healthy children and ado-
lescents [14].1.2.2.3. Pain. Pain was measured by using the Visual Analogue
Scale (VAS), which represents quantitative measurement in terms
of a straight line placed horizontally. Both ends of the line are
labeled with descriptive terms to anchor the extremes of the scale
and to give reference to any point in the continuum between them.
The line was 10 cm in length and each cm has its own number that
reflected the amount of pain. The VAS is the most common and
reliable type of pain scale [18].1.2.3. Procedures
1.2.3.1. Anthropometric measurements. Weight (kg) and height (m)
were recorded using a calibrated floor scale (ZT-120 model), Hang-
zhou Tianheng Technology Co., Ltd. Hangzhou, China. Body mass
index (BMI) was calculated as weight (kg)/height2 (m).1.2.3.2. Handgrip strength. The purpose and steps of the procedure
were explained to the children and their caregivers. Each child was
asked to indicate the dominent hand, any pain at one hand or both,
or any kind of injury or surgery that could affect the result of the
test. The children were seated in front of a table in an appropriately
adjusted chair during measurements. The children sit with the
shoulder adducted, the elbow flexed in a 90 angle, and the fore-
arm and wrist in a neutral position. Before the start of each mea-
surement, the child was asked to handle the dynamometer and
when ready the child was told, ‘‘Squeeze your hand as hard as
you can’’ then release. Three maximum voluntary contractions
were recorded for the dominent hand with a rest period of 5
min. The first attempt is used for familiarization, and the score will
be obtained by averaging the second and third attempts.1.2.3.3. Health related quality of life. The PedsQLTM 4.0 generic core
scale was explained to all children and their caregivers who were
ensured of confidentiality of their information. In the present
study, the questionnaires were distributed among the parents of
children who filled out the questionnaires in the presence of the
investigator. One questionnaire was given to each participant and
the investigator completed the questionnaire with respect to ethi-
cal principles for those patients who were illiterate.1.2.4. Statistical analysis
Descriptive statistics in the form of mean, standard deviation
and frequencies were conducted for data presentation. T-test were
conducted for comparison of the subject characteristics between
groups. Chi-square test was conducted for comparison of sex dis-
tribution and school attendance between both groups. Qol, hand
grip strength and VAS were compared between groups using t test.
The level of significance for all statistical tests was set at p < 0.05.
All statistical measures were performed through the statistical
package for social studies (SPSS) version 19 for windows.
Table 1
Mean age, weight, height and BMI of control and thalassemia group.
normal group Thalassemia group t-value p-value
X ±SD X ±SD
Age (years) 6.71 ± 2.85 6.5 ± 2.9 0.41 0.68*
Weight (kg) 22.63 ± 9.52 21.75 ± 8.87 0.52 0.6*
Height (cm) 113.36 ± 16.72 110.68 ± 16.28 0.89 0.37*
BMI (kg/m2) 16.79 ± 2.89 17.05 ± 3.04 0.49 0.62*
Males/females 35/25 28/32 v2 = 1.63 0.2*
X, Mean; SD, Standard deviation; v2, Chi squared value; p value, Probability value; *, significant.
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2.1. Demographic characteristics of the participants
Sixty children with b-thalassemia major were compared with
30 healthy children. Table 1 showed the mean age, weight, height
and BMI of both groups. There was no significant difference
between both groups in subject characteristic (p > 0.05). In addi-
tion, there was no significant difference in sex distribution
between groups (p = 0.2).2.2. Clinical characteristics of the thalassemia children
There was a positive family history of thalassemia in 63% of the
children. Most children (56.66%) had Hb concentration below
7 g/dl. The age of onset was less than 6 months in 75% of children.
Approximately half of the children (53%) received blood transfu-
sion regularly every 2 weeks. Most of the children (60%) had a his-
tory of splenectomy. Eighty-three percent of our children were
receiving iron-chelation therapy (Table 2).2.3. School attendance
Fifty-eight (97%) of children in the control group were attending
school while 40 (67%) in the thalassemia group were attending
school as shown in Table 3. There was a significant decrease in
school attendance of the thalassemia group compared with that
of the control group (p = 0.0001).Table 2
Clinical characteristics of the thalassemia children.
Clinical data n %




<7 g/dL 34 56.66%
7–9 g/dL 25 41.66%
>9 g/dL 1 1.66%
Age of onset
<6 months 45 75%
6–12 months 9 15%








Every 2 weeks 32 53%
Every 3 weeks 4 7%
Monthly 16 27%
Every 2 Months 8 13%
Hb, hemoglobin; n, number; %, percentage.2.4. Health related quality of life (HRQoL)
Children in the thalassemia group demonstrated significant
reduction in HRQoL measures when compared with the control
group. There was a significant decrease in physical functioning,
emotional functioning, social functioning and school functioning
of the thalassemia group compared with that of the control group
(p = 0.0001). School functioning showed the largest difference with
the control group (MD = 53.95) followed by physical functioning
(MD = 23.31). (Table 4).
2.5. Handgrip strength
There was a significant reduction in handgrip strength of the
thalassemia group compared with the control group (p = 0.0001).
2.6. Pain
There was a significant increase in VAS score of the thalassemia
group compared with control group (p = 0.0001).
3. Discussion
The present study assessed the handgrip strength and HRQoL in
children with b-thalassemia major. The main findings suggested
that children with b-thalassemia major demonstrated lower scores
of handgrips strength associated with poor HRQoL in terms of
physical, emotional, social and school functioning when compared
with the healthy age-matched children.
The results of the present study showed that most of the stud-
ied children in the thalassemia group had positive family history,
history of splenectomy and use of chelation therapy with a per-
centage of 63%, 60% and 83% respectively. These results are consis-
tent with the findings of Ayoub et al. [19] who reported the same
results in Saudi Arabia in family history (64.4%) and use of chela-
tion therapy (87%). However, the history of splenectomy is differ-
ent and registered low percentage (34.8%).
Concerning Hb concentration, the Hb level in the thalassemia
group is much lower than in the healthy age matched children.
These results confirmed those already reported by Galanello and
Origa [20] who reported that patients with thalassemia major are
characterized by reduced Hb level (<7 g/dl) with reduced RBCs
which resulted in microcytic anemia.
In school attendance, the third of the studied children in the
thalassemia group (33%) were not attending school. This high per-
centage means that children with b-thalassemia major were edu-
cationally retarded and demonstrated deficiencies in terms of
academic achievement. The reasons for this retardation could be
explained as the children could not attend school daily due to feel-
ing of fatigue, fear of trauma as well as the need for frequent blood
transfusions. These results come in agreement with Pakbaz et al.
[21] and Ayoub et al. [19] who reported that thalassemia patients
showed decreased academic achievement, which was due to fre-
quent absence from the school for visiting health care centers
Table 4
Comparison of HRQol, strength and pain between the control and thalassemia group:
Control group Thalassemia group MD t-value p-value
X ±SD X ±SD
Physical functioning 85.1 ± 10.23 61.79 ± 18.59 23.31 8.5 0.0001**
Emotional functioning 84.08 ± 9.45 71.08 ± 17.78 13 5 0.0001**
Social functioning 92.5 ± 7.33 73.91 ± 17.99 18.59 7.4 0.0001**
School functioning 85.2 ± 17.62 31.25 ± 25.9 53.95 13.34 0.0001**
Hand grip strength (lb) 1.96 ± 1.14 0.93 ± 0.74 1.03 5.84 0.0001**
Pain (VAS) 0 ± 0 6.28 ± 1.8 6.28 -26.96 0.0001**
X, Mean; SD, Standard deviation; MD, Mean difference; p value, Probability value; **, Significant.
Table 3
The frequency distribution and chi squared test for comparison of school attendance between both groups (the control and thalassemia).
Control group Thalassemia group v2 p-value Sig
Attending school 58 (97%) 40 (67%) 18.03 0.0001 S
Not attending school 2 (3%) 20 (33%)
v2, Chi square value; p value, Probability value; S, Significant.
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ization as well as physical and mental problems.
The decreased values of handgrip strength in children with tha-
lassemia could be attributed to increased pain in the joints,
decreased exercise capacity and physical function in these chil-
dren. These results corroborate with the findings of Jagoe and
Engelen, [22] who reported that the presence of pain that may
involve the functional status in patients with thalassemia could
result in less muscular work and a consequent change in muscle
protein metabolism that can lead to peripheral muscle weakness
over time. Decreased handgrip strength in children with tha-
lassemia may be due to the significant long-term consequences
of chronic transfusion on nutrition, physical activity, and growth
[23]. These results were supported by the findings of Boot et al.
[24] who reported that body composition is influenced by many
factors including age, gender, gonadal status, nutrition, exercise,
and hormonal factors. Moreover, the decreased hemoglobin levels
could result in decreased muscular strength in these children, as
lower hemoglobin level is associated with a number of symptoms,
such as fatigue, general weakness and decreased mental alertness,
which may lead to impaired HRQoL [25].
The results of the present study demonstrated that school func-
tioning domain was the most affected domain followed by physi-
cal, emotional and social functioning respectively in QoL in
children with thalassemia. These results are the same and consis-
tent with the findings of Ayoub et al. [19], Thavorncharoensap
et al. [26] and Ismail et al. [27] who reported that school function-
ing had a lower score followed by physical, emotional and social
functioning. This could be explained by the fact that frequent
absence from school for hospital visits, and lack of energy when
performing academic activities, had a significant negative impact
on the children’s HRQoL [14,28].
The findings of this study are consistent with the observations of
Ismail et al. [14], who investigated the effect of thalassemia on chil-
dren (age, 5–18 years) compared with healthy children (age, 7–18
years) in terms of physical, emotional, social and school functioning
using the PedsQL 4.0 generic scale score. They concluded that tha-
lassemia has a negative impact on all themeasured variables in chil-
dren with thalassemia compared with the healthy controls.
The results of the current study also confirm those already
reported by Baraz et al. [29] who compared the QoL between 65
adolescents with beta thalassemia major (age, 14–18 years) and
their healthy peers with the same number and age. They concluded
that the adolescents with beta thalassemia had lower QoL com-pared with their healthy age-matched subjects. Similarly, Gharai-
beh and Gharaibeh [30] compared the outcomes of PedsQL
obtained on a sample of 128 Jordanian thalassemic children aged
8–18 years with those of 83 healthy children. The patients had sig-
nificantly lower HRQoL mean scores in all dimensions compared to
their healthy peers.
Increased pain scores in children with thalassemia could be
attributed to low hemoglobin concentration, low bone mass, and/
or iron overload.Moreover, as individualswith thalassemia increase
in age, pain becomesmore common,more severe and the number of
sites of pain increase. Pain interferes with multiple dimensions of
life, particularly emotional and physical functioning [13].
This is also consistent with Trachtenberg et al. [31] who
reported that patients with thalassemia as they age frequently
complain of ‘‘throbbing back pain” in the week before transfusion.
Practitioners generally assumed that bone marrow activity and
pressure are increased, which are subsequently suppressed after
blood transfusion. This assumption is supported by 34% of patients
reported improvement of pain with transfusion. Marrow expan-
sion could also be a source of pain.
Some limitations to this study should be recognized. The rela-
tively small sample size that limit the generalizability of the find-
ings. In addition, lack of previous studies that assessed muscle
strength in children with thalassemia that limit the comparison
of our data with other studies. There is a need for conducting more
research on cardiopulmonary strength and fitness and their rela-
tionship with functional and social activity in these children.4. Conclusion
Thalassemia as a chronic disease has a negative impact on mus-
cle strength, pain and HRQoL in terms of physical functioning,
emotional, social and school functioning when compared with
the healthy age-matched children. Therefore, intervention pro-
grams emphasizing spiritual growth, physical activity and inter-
personal relations are necessary for children with thalassemia.Acknowledgement
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